Procurement Summary
Country: USA
Summary: Isotopes for isotopically labeling proteins for solution Nuclear Magnetic Resonance (NMR) investigation
Deadline: 18 Aug 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 124303591
Document Ref. No.: 75N94025Q00177
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
This is a combined synopsis/solicitation for commercial products or services prepared in accordance with the format in FAR 12.6 (Streamlined Procedures for Evaluation and Solicitation for commercial items) as applicable, and as supplemented with additional information included in this notice. This acquisition will be processed in accordance with FAR Part 13 - Simplified Acquisition Procedures (SAP) for Certain Commercial Products and Services. This announcement constitutes the solicitation; quotes are being requested and a separate written solicitation will not be issued. This solicitation number is 75N94025Q00177 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2025-04 (May 12, 2025).
The North American Industry Classification (NAICS) Code is 325412 and the business size standard is 1, 300 employees.
This solicitation is NOT set aside for total small businesses.
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on behalf of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to award a Firm Fixed Price (FFP) purchase order through full and open competition to fulfill this requirement.
Active Contract Opportunity
Notice ID : 75N94025Q00177
Related Notice
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : NATIONAL INSTITUTES OF HEALTH
Office: NATIONAL INSTITUTES OF HEALTH NICHD
General Information
Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
Original Published Date: Aug 11, 2025 04:31 pm EDT
Original Date Offers Due: Aug 18, 2025 01:00 pm EDT
Inactive Policy: 15 days after date offers due
Original Inactive Date: Sep 02, 2025
Initiative: None
Classification
Original Set Aside: No Set aside used
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Place of Performance: Bethesda, MD 20892 USA
Documents
Tender Notice
ATT-4.pdf
ATT-3.pdf
ATT-2.pdf
ATT-5_Invoicing-Instructions-With-IPP.pdf
ATT-1.pdf
Combined-Synopsis-Solicitation.pdf